CVE-2019-13157 Path traversal in Naver Vaccine

High 7.5 Published Updated

Remote attackers can overwrite arbitrary files via directory traversal in Naver Vaccine archives, potentially compromising system integrity.

Exploited in the wild
Not known
Login needed
Not needed
Attackable
Over the internet
Victim action needed
Not needed
Fix
None listed

What is CVE-2019-13157?

CVE-2019-13157 is a high-severity path traversal vulnerability in Naver Vaccine, published on 22 Nov 2019. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.

Weakness: CWE-22

Which versions are affected by CVE-2019-13157?

It affects 1 product.

Products include Naver Vaccine.

How do I fix CVE-2019-13157?

No fix has been published for CVE-2019-13157 yet. Limit exposure of the affected software until one is available.

Upgrade, and resolve every user-supplied path against an allowed base folder before opening it. More about Path traversal.

Is CVE-2019-13157 being exploited?

There is no known exploitation of CVE-2019-13157 in the wild and no public exploit code.

Sources

Also known as GHSA-94vf-fjjv-7qh2.

Is CVE-2019-13157 in your software?

Upload an SBOM and sbomify checks it against every vulnerability here, every day.

Check your SBOMs for free